Actuate Therapeutics, Inc. (ACTU)
NASDAQ: ACTU · Real-Time Price · USD
0.6102
-0.0688 (-10.13%)
At close: Oct 9, 2026, 4:00 PM EDT
0.6200
+0.0098 (1.61%)
After-hours: Oct 9, 2026, 7:26 PM EDT
Actuate Therapeutics Market Cap
Actuate Therapeutics has a market cap or net worth of $14.65 million as of October 9, 2026. It is the 39,348th most valuable company in the world and the 5,425th biggest in the United States. Its market cap has decreased by 90.88% in one year.
Market Cap
14.65M
Enterprise Value
10.23M
1-Year Change
-90.88%
Global Rank
Country Rank
#5,425 United States
Category
ChartMarket Cap Chart
Since the IPO on August 13, 2024, Actuate Therapeutics's market cap has decreased from $152.13M to $14.65M, a decrease of -90.37%. That is a compound annual growth rate of -66.22%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 9, 2026 | 14.65M | -89.70% |
| Dec 31, 2025 | 142.25M | -8.50% |
| Dec 31, 2024 | 155.47M | 2.20% |
| Aug 13, 2024 | 152.13M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Pasithea Therapeutics | 15.62M |
| Palatin Technologies | 15.51M |
| Radiopharm Theranostics | 15.13M |
| Vyome Holdings | 14.67M |
| Cerenome | 14.65M |
| Lipocine | 14.18M |
| AEON Biopharma | 13.77M |
| Tvardi Therapeutics | 13.74M |